Surgery Partners, Inc. (SGRY)

Over the past six months, Surgery Partners' stock has experienced volatility and a general decline, though with some recent rebound. In the Q3 2025 earnings report, Surgery Partners reported an EPS of $0.13, missing analysts' consensus estimates. Analyst price target adjustments occurred in November 2025 from JPMorgan Chase & Co., Barclays, and Mizuho. In Q2 2025, the company announced strong growth in Adjusted EBITDA and revenue. In Q1 2025, Surgery Partners reported increased net revenue and Adjusted EBITDA. Concerns have been raised due to insider selling activity. The stock recovered nearly 9% over the past month, indicating a reassessment of the company's prospects by investors.

Surgery Partners experiences some demand seasonality, particularly in its cash flow, with the first quarter typically lower due to seasonal patterns and working capital timing. The company operates in the outpatient surgical industry, which is experiencing significant demand driven by advancements in medical technology and a growing preference for minimally invasive procedures. The ongoing migration of higher-acuity cases from hospitals to outpatient settings is strengthening, which benefits Surgery Partners.

Surgery Partners, Inc. (SGRY) is a healthcare services company specializing in surgical facilities and ancillary services in the United States. Founded in 2004, the company operates within the outpatient surgical industry, focusing on acquiring, developing, and managing ambulatory surgery centers (ASCs) and surgical hospitals. The company's primary business segments include Surgical Facilities, encompassing ASCs and surgical hospitals providing non-emergency surgical procedures, and Ancillary Services, which support the surgical facilities and include diagnostic imaging, laboratory services, and other related offerings.

Surgery Partners operates a network of surgical facilities and ancillary services across the United States. As of November 2025, the company has more than 250 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities. This broad geographic reach allows the company to serve a diverse patient population and collaborate with a wide array of physicians and healthcare professionals.

The provided information does not contain specific details about events that have explicitly affected Surgery Partners, Inc.'s brand reputation in the past year. However, the company is described as a leading national provider of surgical services, dedicated to improving patient outcomes and enhancing the quality of care through efficient, accessible, and cost-effective surgical solutions.

Surgery Partners, Inc.'s ownership is significantly influenced by institutional investors, including affiliates of Bain Capital Private Equity, Janus Henderson Group Plc, and others. Blair E. Hendrix is noted as the largest individual shareholder, followed by T. Devin Oreilly and Andrew T. Kaplan.